logo
16:01 Dec 05

Norris Medicines Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
15.00
+0.33 (+2.25%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Norris Medicines Ltd. Financials

Norris Medicines Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
15.00
+0.33 (+2.25%)
16:01 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

15/100
Expensive Valuation

Technical

29/100
Technically Bearish

Strength

2

Weakness

7

Opportunity

0

Threats

0

-449.77 %

ROE %

-8.96 %

ROA %

0.00

EPS

-14.98

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
9.44 8.36 5.64 5.82 6.56
Operating Expenses +
9.51 7.44 5.82 6.08 6.75
Raw Material
3.57 3.23 3.16 3.37 3.74
Increase Decrease in Cost
2.04 0.13 -0.5 0.08 0.27
Other Manufacturing Expense
0 1.27 0 0 0
Employee Cost
2.33 2.3 1.82 1.41 1.47
Miscellaneous Expenses
1.57 0.51 1.34 1.22 1.27
Operating Profit
-0.07 0.92 -0.18 -0.26 -0.19
Other Income
0.03 0.01 0.03 0.06 0.07
Depreciation
0.66 0.63 0.57 0.54 0.52
Interest
1.48 1.5 0.37 0.44 0.46
Profit before tax and exceptio..
-2.18 -1.19 -1.1 -1.18 -1.1
Exceptional Items
0 0 0 0 0
PBT
-2.18 -1.19 -1.1 -1.18 -1.1
Provision for Taxation
1.08 0.56 0.09 0.06 0.06
Net Profit
-3.26 -1.75 -1.19 -1.24 -1.18
NET Profit after MI
0 0 0 0 0
EPS
-3.26 -1.75 -1.19 -1.24 -1.18
Operating Profit Margin (%)
-0.74 11 -3.19 -4.47 -2.9
Net Profit Margin (%)
-34.53 -20.93 -21.1 -21.31 -17.99

Norris Medicines Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 34.00 34.00 34.00 34.00 34.00 34.00
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.10 0.10 0.10 0.10 0.10 0.10
Others 65.90 65.90 65.90 65.90 65.90 65.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: